From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves Merck's new hepatitis C pill

from Reuters

U.S. regulators approved a new once-daily pill for the liver-destroying hepatitis C virus made by Merck & Co. Inc., which said it will sell the drug at a lower list price than its competitors. The list price for Zepatier will be $54,600 for a 12-week regimen, which Merck said it expects "to be in the range of net prices" for comparable treatments. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063